A PILOT STUDY TO EVALUATE THE EFFECTS OF SUBCUTANEOUSLY ADMINISTERED RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR IN PEDIATRIC HIV-INFECTED PATIENTS WITH NEUTROPENIA SECONDARY TO AZIDOTHYMIDINE: